A disease chapter · the one we hold most carefully

Type 3
Diabetes?

Some researchers nickname Alzheimer's "type 3 diabetes." It's a provocative idea with real evidence behind it — and real limits. This chapter is built to separate what's settled from what's still only a hopeful guess, because on a subject this heavy, the honesty matters more than the headline.

Scroll to begin
Where the phrase came from

A nickname, not a diagnosis.

The term "type 3 diabetes" was put forward in 2008 by a group of researchers who had noticed how much the Alzheimer's brain looked, metabolically, like a diabetic organ — and who argued the resemblance was worth taking seriously.[1] It was a deliberately provocative label, meant to shake loose a new way of thinking about a disease that has defeated almost every treatment aimed at it.

So before anything else, the honest caveat, stated plainly: "type 3 diabetes" is a research nickname, not a diagnosis. No doctor will write it on your notes. It is not in any diagnostic manual. And Alzheimer's is genuinely multifactorial — age, genetics (especially the APOE4 gene), the amyloid and tau proteins, blood-vessel health and inflammation all play real parts. Insulin and metabolism are one thread in that weave, not the whole cloth.

This is also the most sensitive subject on the site. If dementia has touched your family, please read this as careful information, not as a promise or a blame. There is no known way to simply prevent or reverse Alzheimer's — and nobody honest will tell you otherwise.
What's solid · part one

Metabolic health and brain health travel together.

Start with the part that is well-established and replicated across very large studies: people with type 2 diabetes have a substantially higher risk of developing dementia — on the order of around 60% higher than people without it, in a pooled analysis of more than 2.3 million people.[3] The link holds across countries and decades.

That's an association — a risk factor, not a verdict. It doesn't prove that diabetes causes the dementia; shared roots (blood-vessel damage, high blood sugar, the whole metabolic fire) could drive both. But it's a strong, consistent signal that whatever is burning in the body in type 2 diabetes is not leaving the brain untouched.

The organ with the body's highest fuel demand is unlikely to sit out a fuel-handling disease.
What's solid · part two

The insulin machinery falters inside the brain.

The brain was long thought to be "insulin-independent" — it takes up glucose without needing insulin the way muscle does. But the brain is full of insulin receptors, and insulin does real jobs there: in memory, in how neurons connect, in their upkeep. And when researchers examined the actual brain tissue of people who had died with Alzheimer's, they found the insulin-signalling pathway measurably broken — the same kind of resistance seen in a diabetic muscle or liver, but in neurons.[2]

This is the observation at the heart of the whole "type 3" idea, and the observation itself is solid: in the Alzheimer's brain, the cells that should respond to insulin have gone partly deaf to it, and the degree of that deafness tracks with how much the person's thinking had declined.[2] A brain struggling to hear its own fuel-and-maintenance signal is a brain in trouble.

What's genuinely established here: the association between diabetes and dementia, and the presence of disrupted insulin signalling in Alzheimer's brains. Those are the firm stones. The next step — saying the resistance causes the disease — is where the ground gets soft.
Where it becomes a hypothesis

Cause, or consequence, or companion?

Here's the hard question the nickname leaps over. We can see insulin resistance in the Alzheimer's brain — but is it a cause of the damage, a consequence of it, or a companion riding alongside the real culprits? A sick, degenerating neuron might lose its insulin response because it's dying, not die because it lost it. Both stories fit the snapshot.

Held as a hypothesis, not a headline. That brain insulin resistance is a driver of Alzheimer's — the full strength of the "type 3 diabetes" claim — is a serious, actively-researched idea, and it may well turn out to carry real weight. But it is not established, and this chapter does not lean on it. The honest status is: a promising hypothesis with suggestive evidence, not a proven cause. Anyone stating "Alzheimer's is diabetes of the brain" as settled fact has crossed from the evidence into the hope.

That uncertainty isn't a weakness to hide — it's the actual state of the science, and you deserve it straight.

Try it yourself

Sort the claim.

This is the skill the whole site is really about: telling settled science from an open question from an overclaim. Here are six statements you'll meet about Alzheimer's and metabolism. For each, decide where it belongs — then see how it actually stands.

Settled, open, or overclaim?
Pick a tier for each claim. There's no catching you out — the point is to feel the difference.
Claim 1 of 6
Settled Open question Overclaim

If a few of those surprised you, that's the point. The same subject holds rock-solid facts, genuine open questions, and confident-sounding overclaims all at once — and the difference between them is exactly what gets lost when "type 3 diabetes" becomes a headline.

The honest test that didn't deliver

So they tried giving the brain insulin.

If brain insulin resistance drives Alzheimer's, there's an obvious thing to try: get more insulin to the brain and see if thinking improves. You can do it with a nasal spray, which carries insulin up toward the brain while mostly bypassing the bloodstream. It's the most direct test of the whole idea — and it's been run as a proper randomised trial.

The largest such trial, published in 2020, did not find a benefit on its main measure of thinking and memory.[4] The result was muddied by a malfunctioning spray device partway through, so it isn't a clean "no" either — but it is certainly not the clean "yes" the hypothesis would have predicted. The honest summary is: the most direct test we have, so far, has not worked.

Why include a disappointing result? Because leaving it out would be exactly the dishonesty this site exists to avoid. A hypothesis is only as trustworthy as its willingness to be tested — and when the test underwhelms, you're owed that news as plainly as the hopeful parts. It doesn't kill the idea; it keeps it honest.
What you can and can't take from this

Hopeful, not magical.

So where does an honest reading leave you? Not with a cure, and not with a reason to despair — somewhere more useful than either.

  • You can't "cut sugar to prevent Alzheimer's." No one has shown that any diet prevents or reverses the disease. Claiming otherwise is an overclaim, however well-meant.
  • But metabolic health and brain health clearly travel together. Looking after blood sugar, blood pressure, weight, sleep and activity is among the few things genuinely linked to lower dementia risk across the research — and it's good for the rest of you regardless. That's a sound bet even while the "type 3" question stays open.
  • The brain is not sealed off from the fire. Whatever the final verdict on cause, a body that's metabolically on fire is not giving its most fuel-hungry organ the easiest conditions. Cooling that fire is reasonable, low-risk, and yours to do.
The safety line. If you or someone you love is facing memory problems or a dementia diagnosis, that belongs with doctors — for assessment, support, and whatever treatment fits. Nothing here replaces that care, and nothing here is a reason to delay seeking it. Metabolic health is something to add to good medical care, never a substitute for it.
Where this leaves you

A thread worth pulling, gently.

"Type 3 diabetes" is the right kind of question wearing the wrong kind of certainty. The thread is real: the diabetic body raises dementia risk, and the Alzheimer's brain shows the fingerprints of broken insulin signalling. Whether that thread is a cause, a consequence, or a companion is genuinely unknown — and the most direct attempt to tug on it hasn't yet paid off.

Take the fire seriously for the brain's sake too — without pretending we know more than we do.

Ask your body what's feeding the fire — and hold the brain's part of the story with open hands.

One more organ, watching the same fire. Back to the whole: The Invisible Fire. On reading claims like these: How Risk Is Sold.

A final word

The honest shape of a hard subject.

A firm link between metabolic disease and dementia. Real, measurable insulin trouble inside the Alzheimer's brain. A bold hypothesis that ties them together — still unproven, and not yet borne out by its most direct test. That's the honest shape of it: enough to take the metabolic fire seriously for the brain, not enough to promise anything. On this subject above all, that restraint is the respect it's owed.

Serious about the fire. Honest about the limits. Gentle with the people living this.

Verified references

[1] de la Monte SM, Wands JR (2008). Alzheimer's disease is type 3 diabetes — evidence reviewed. J Diabetes Sci Technol 2(6):1101-1113. PMID 19885299. (Origin of the "type 3 diabetes" proposal — a research argument, not a clinical diagnosis.) Read →

[2] Talbot K, Wang HY, Kazi H, et al. (2012). Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122(4):1316-1338. PMID 22476197. (Direct evidence of disrupted insulin signalling in Alzheimer's brain tissue.) Read →

[3] Chatterjee S, Peters SAE, Woodward M, et al. (2016). Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 39(2):300-307. PMID 26681727. (Epidemiological link — around 60% higher dementia risk with type 2 diabetes.) Read →

[4] Craft S, Raman R, Chow TW, et al. (2020). Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial. JAMA Neurol 77(9). PMID 32568367. (The most direct trial of the hypothesis — no benefit on the primary cognitive outcome; complicated by a device malfunction.) Read →

Tiering note: references [1] and [2] establish that insulin signalling is disrupted in the Alzheimer's brain and that the "type 3" idea was seriously proposed — not that insulin resistance has been proven to cause the disease. Reference [4] is included precisely because its result was disappointing: the honest record includes the tests that didn't work.